GLSI: Greenwich LifeSciences, Inc. Stock

by  •  • Comments Off on GLSI: Greenwich LifeSciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 153.40
Enterprise Value ($M) 147.58
Book Value ($M) 4.98
Book Value / Share 0.38
Price / Book 30.79
NCAV ($M) 4.98
NCAV / Share 0.38
Price / NCAV 30.80

Profitability (mra)
Return on Invested Capital (ROIC) -2.11
Return on Assets (ROA) -1.50
Return on Equity (ROE) -1.57

Liquidity (mrq)
Quick Ratio 6.91
Current Ratio 6.91

Balance Sheet (mrq) ($M)
Current Assets 5.82
Assets 5.83
Liabilities 0.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-12 11,700 20,359 57.47
2025-03-11 2,134 7,623 27.99
2025-03-10 7,157 18,255 39.21
2025-03-07 6,585 21,048 31.29

(click for more detail)

Similar Companies
GDTC – CytoMed Therapeutics Limited GELS – Gelteq Limited
GLMD – Galmed Pharmaceuticals Ltd. GLTO – Galecto, Inc.
GLYC – GlycoMimetics, Inc.


Financial data and stock pages provided by
Fintel.io